<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Hyperprolactinemia • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Hyperprolactinemia • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/hyperprolactinemia/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/hyperprolactinemia/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="hyperprolactinemia" tabindex="-1">hyperprolactinemia</h1>
<ul>
<li>related: <a href="/wiki/notes/Endocrine/">Endocrine</a>, <a href="/wiki/notes/prolactinoma%20and%20pregnancy/">prolactinoma and pregnancy</a>, <a href="/wiki/notes/prolactinoma/">prolactinoma</a></li>
<li>tags: #endocrine</li>
</ul>
<hr>
<!-- hyperprolactinemia causes, sx, -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220813093101.png" alt=""></p>
<p>Causes of high prolactin:</p>
<ul>
<li>
<p>most common cause:</p>
<ul>
<li>physiologic (pregnancy and lactation)</li>
<li>physiologic stress, coitus, sleep, nipple stimulation</li>
</ul>
</li>
<li>
<p>pathologic:</p>
<ul>
<li>primary hypothyroidism</li>
<li>pituitary stalk compression</li>
<li>medications: antipsychotics, usually 25-100 ng/mL
<ul>
<li>metoclopramide, risperidone, phenothiazine can cause &gt; 200ng/mL</li>
</ul>
</li>
</ul>
</li>
</ul>
<p>This patient has <strong>hyperprolactinemia</strong>, most likely due to <strong>chronic kidney disease</strong> (CKD).  Hyperprolactinemia is common in CKD due to a 3-fold increase in prolactin release (as a result of an altered inhibitory effect of dopamine) and a 30% decrease in prolactin clearance.  Prolactin levels are usually modestly elevated (<strong>&lt;100 ng/mL</strong>).</p>
<p>Prolactin levels in patients with CKD do not respond to hemodialysis but can be normalized with dopamine agonists (eg, bromocriptine, cabergoline).  However, sexual dysfunction often persists due to additional contributing factors (eg, neuropathy, vascular disease, medications).  Low serum testosterone levels also are common in CKD, but testosterone therapy does not improve symptoms in most patients.</p>
<p>Symptoms:</p>
<ul>
<li>amenorrhea, galactorrhea in premenopausal women</li>
<li>men: mass effect, hypogonadism, gynecomastia</li>
</ul>
<!-- prolactinoma management -->
<p>Management</p>
<ul>
<li>
<p>Discontinue offending drug for 3 days to determine whether level normalizes</p>
</li>
<li>
<p>Antipsychotic drug needs to be discontinued in consultation with psychiatrist</p>
</li>
<li>
<p><strong>Perform pituitary MRI if cannot discontinue drug</strong> (this means everyone on antipsychotics)</p>
</li>
<li>
<p>MRI pituitary indicated in all patients with unexplained high prolactin</p>
</li>
<li>
<p>macroprolactinoma (≥1 cm)</p>
<ul>
<li>prolactin &gt; 500 ng/mL diagnostic of macroprolactinoma</li>
<li>prolactin correlate with tumor size</li>
<li>when macroadenoma present with prolactin &lt; 100, cause usually from stalk compression from nonfunctioning tumor and not from prolactionoma</li>
<li>dopamine agonist used as treatment
<ul>
<li>cabergoline: preferred, more efficacious at lowering prolactin and shrink tumor. Dosed weekly</li>
<li>bromocriptine: dosing qd to tid</li>
</ul>
</li>
<li>monitor prolactin level 2-4 wks then 3-4 months</li>
<li>repeat MRI in 3 months, then every 6-12 months until stability</li>
<li>surgery not first line: 50% recur after resection</li>
<li>only consider surgery if cannot tolerate medication or fails medication</li>
</ul>
</li>
<li>
<p>microadnoma:</p>
<ul>
<li>asymptomatic pts do not require treatment</li>
<li>premenopausal women with hypogonadism treated with OCP if do not want children or dopamine agonist if do want children</li>
<li>postmenopausal women: no treatment</li>
<li>repeat MRI in 1 year</li>
</ul>
</li>
</ul>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Endocrine/" class="peer">Endocrine</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="endocrine" tabindex="-1">Endocrine</h1>
<ul>
<li>related: <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/Disorders%20of%20Glucose%20Metabolism/">Disorders of Glucose Metabolism</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Pituitary%20Gland/">Disorders of the Pituitary Gland</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Adrenal%20Glands/">Disorders of the Adrenal Glands</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Thyroid%20Gland/">Disorders of the Thyroid Gland</a></li>
<li><a href="/wiki/notes/Reproductive%20Disorders/">Reproductive Disorders</a></li>
<li><a href="/wiki/notes/Transgender%20Hormone%20Therapy%20Management/">Transgender Hormone Therapy Management</a></li>
<li><a href="/wiki/notes/Calcium%20and%20Bone%20Disorders/">Calcium and Bone Disorders</a></li>
</ul>
<h2 id="pituitary" tabindex="-1">Pituitary</h2>
<ul>
<li><a href="/wiki/notes/pituitary%20adenoma/">pituitary adenoma</a></li>
<li><a href="/wiki/notes/inappropriately%20normal%20TSH%20could%20be%20sign%20of%20central%20hypothyroidism/">inappropriately normal TSH could be sign of central hypothyroidism</a></li>
<li><a href="/wiki/notes/pituitary%20apoplexy/">pituitary apoplexy</a></li>
<li><a href="/wiki/notes/MEN/">MEN</a></li>
<li><a href="/wiki/notes/hyperprolactinemia/">hyperprolactinemia</a></li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/prolactinoma and pregnancy/" class="peer">Prolactinoma and Pregnancy</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="prolactinoma-and-pregnancy" tabindex="-1">prolactinoma and pregnancy</h1>
<ul>
<li>related: <a href="/wiki/notes/hyperprolactinemia/">hyperprolactinemia</a></li>
</ul>
<!-- prolactionoma management in pregnancy -->
<p>Due to lactotroph hyperplasia in pregnancy, there is concern for enlargement of prolactinomas in pregnancy. Because microadenomas are not likely to enlarge during pregnancy, dopamine agonist therapy should be discontinued when pregnancy is discovered. However, patients who have macroadenomas without prior surgical or radiation therapy have a significant risk of tu</p>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
